The decreased IC50 values also supported that knocking down PBX3 sensitized HCT116 cells to 5-FU and oxaliplatin, which was prevented by overexpressing G6PD. Together, these results confirm that G6PD is crucial for PBX3 regulation of tumor cell PPP. Here, PBX3 is linked to neoplasm.